Concepedia

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

Kelly D. DeWitt, Howard M. Sandler, Vivian Weinberg, Patrick W. McLaughlin, Mack Roach

Urology · 2003 · 24 citations · 23 references

DOI

Concepts

References

23

Consensus statement: Guidelines for PSA following radiation therapy1

AMERICANSOCIETYFORTHERAPEUTICR · International Journal of Radiation Oncology*Biology*Physics · 1997 · 1.2K citations

, , +14

Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment Outcome

Anthony L. Zietman, John J. Coen, William U. Shipley et al. · The Journal of Urology · 1994 · 257 citations

, , +17

Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: Followup

Irving Kaplan, Richard S. Cox, Malcolm A. Bagshaw · The Journal of Urology · 1993 · 178 citations

, , +15

Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survival

W. Robert Lee, Alexandria L. Hanlon, Gerald E. Hanks · The Journal of Urology · 1996 · 133 citations

, , +12

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.

Thomas M. Pisansky, S S, John D. Earle et al. · Journal of Clinical Oncology · 1993 · 129 citations

, , +17